- Home
- CGON vs UVV Comparison
CGON vs UVV Comparison
Compare CGON & UVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGON
- UVV
- Stock Information
- Founded
- CGON 2010
- UVV 1886
- Country
- CGON United States
- UVV United States
- Employees
- CGON N/A
- UVV N/A
- Industry
- CGON
- UVV Farming/Seeds/Milling
- Sector
- CGON
- UVV Industrials
- Exchange
- CGON NYSE
- UVV Nasdaq
- Market Cap
- CGON 1.3B
- UVV 1.3B
- IPO Year
- CGON 2024
- UVV N/A
- Fundamental
- Price
- CGON $25.62
- UVV $65.32
- Analyst Decision
- CGON Strong Buy
- UVV
- Analyst Count
- CGON 10
- UVV 0
- Target Price
- CGON $64.00
- UVV N/A
- AVG Volume (30 Days)
- CGON 1.4M
- UVV 213.6K
- Earning Date
- CGON 05-13-2025
- UVV 05-29-2025
- Dividend Yield
- CGON N/A
- UVV 5.02%
- EPS Growth
- CGON N/A
- UVV N/A
- EPS
- CGON N/A
- UVV 3.78
- Revenue
- CGON $662,000.00
- UVV $2,947,284,000.00
- Revenue This Year
- CGON N/A
- UVV N/A
- Revenue Next Year
- CGON $12,387.03
- UVV N/A
- P/E Ratio
- CGON N/A
- UVV $15.71
- Revenue Growth
- CGON 224.51
- UVV 7.23
- 52 Week Low
- CGON $14.80
- UVV $45.19
- 52 Week High
- CGON $40.47
- UVV $67.33
- Technical
- Relative Strength Index (RSI)
- CGON 53.27
- UVV 79.23
- Support Level
- CGON $24.79
- UVV $58.68
- Resistance Level
- CGON $26.60
- UVV $60.19
- Average True Range (ATR)
- CGON 1.39
- UVV 1.63
- MACD
- CGON -0.01
- UVV 0.46
- Stochastic Oscillator
- CGON 48.52
- UVV 83.95
About CGON CG ONCOLOGY INC
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
About UVV Universal Corporation
Universal Corp is a global leaf tobacco supplier. The company procures leaf tobacco from farmers, processes it, and sells it to companies that manufacture consumer tobacco products. Universal does not manufacture or sell any consumer products itself. The company's segment includes Tobacco Operations and Ingredients Operations. It generates maximum revenue from the Tobacco Operations segment. Geographically, it derives a majority of revenue from the United States.